Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches
Chronic kidney disease (CKD) is a major public health concern that affects around 10 percent of the world’s population. The severity of CKD is mainly due to the high prevalence of cardiovascular (CV) complications in this population. The aim of this review is to describe the arterial remodelling ass...
Main Authors: | Nabil Foudi, Maeva Palayer, Marie Briet, Anne-Sophie Garnier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/17/3803 |
Similar Items
-
Dietary Fibre Intake Is Associated with Serum Levels of Uraemic Toxins in Children with Chronic Kidney Disease
by: Amina El Amouri, et al.
Published: (2021-03-01) -
Coma caused by Shigella toxin-producing <em>Escherichia coli </em> in the absence of haemorrhagic uraemic syndrome (HUS)
by: Kristien Velding, et al.
Published: (2016-07-01) -
Sponge-like Chitosan Based Porous Monolith for Uraemic Toxins Sorption
by: Siyu Xiong, et al.
Published: (2021-08-01) -
Metabolic studies on the uraemic rat
by: Klim, R. A.
Published: (1984) -
Chronic Kidney Disease-Associated Itch (CKD-aI) in Children—A Narrative Review
by: Radomir Reszke, et al.
Published: (2021-06-01)